Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$216M |
| 2 |
Charter Communications
CHTR
|
+$192M |
| 3 |
SLB Ltd
SLB
|
+$79.3M |
| 4 |
IBM
IBM
|
+$70.2M |
| 5 |
Newell Brands
NWL
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AFFX
Affymetrix Inc
AFFX
|
+$7.53B |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$447M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$229M |
| 4 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$208M |
| 5 |
SANDISK CORP
SNDK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.87% |
| 2 | Technology | 14.38% |
| 3 | Financials | 13.98% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
DELISTED
Discover Financial Services
DFS
| $193M | 0.11% |
3,612,122
+10,432
| +0.3% | +$567K |
2013 Q2
12 quarters
|
|
202
Zimmer Biomet
ZBH
$17B
| $193M | 0.11% |
1,655,475
+154,180
| +10% | +$17.4M |
2013 Q2
12 quarters
|
|
203
DELISTED
SunTrust Banks, Inc.
STI
| $189M | 0.1% |
4,611,726
+153,804
| +3% | +$6.29M |
2013 Q2
12 quarters
|
|
204
Deere & Co
DE
$167B
| $189M | 0.1% |
2,332,929
-51,103
| -2% | -$4.19M |
2013 Q2
12 quarters
|
|
205
Tyson Foods
TSN
$18.8B
| $189M | 0.1% |
2,829,031
+113,783
| +4% | +$7.38M |
2013 Q2
12 quarters
|
|
206
Boston Properties
BXP
$9.43B
| $188M | 0.1% |
1,425,540
-43,163
| -3% | -$5.54M |
2013 Q2
12 quarters
|
|
207
DELISTED
Paramount Global Class B
PARA
| $187M | 0.1% |
3,438,759
+150,411
| +5% | +$8.17M |
2013 Q2
12 quarters
|
|
208
HP
HPQ
$27.2B
| $186M | 0.1% |
14,865,228
-238,174
| -2% | -$2.97M |
2013 Q2
12 quarters
|
|
209
Monster Beverage
MNST
$85.5B
| $186M | 0.1% |
13,917,576
-2,011,200
| -13% | -$24.3M |
2015 Q3
3 quarters
|
|
210
Dollar Tree
DLTR
$22.3B
| $186M | 0.1% |
1,973,546
+1,707
| +0.1% | +$144K |
2013 Q2
12 quarters
|
|
211
Synchrony
SYF
$23.7B
| $182M | 0.1% |
7,200,613
-341,470
| -5% | -$9.94M |
2014 Q3
7 quarters
|
|
|
STJ
212
DELISTED
St Jude Medical
STJ
| $181M | 0.1% |
2,329,983
-417,965
| -15% | -$29.8M |
2013 Q2
12 quarters
|
|
213
HCA Healthcare
HCA
$97.7B
| $178M | 0.1% |
2,314,339
-122,174
| -5% | -$9.64M |
2013 Q2
12 quarters
|
|
214
Progressive
PGR
$126B
| $177M | 0.1% |
5,297,699
-247,424
| -4% | -$8.19M |
2013 Q2
12 quarters
|
|
215
T. Rowe Price
TROW
$22.4B
| $174M | 0.09% |
2,390,829
+50,689
| +2% | +$3.77M |
2013 Q2
12 quarters
|
|
|
216
Newell Brands
NWL
$2.4B
| $174M | 0.09% |
3,592,627
+1,443,501
| +67% | +$67.5M |
2013 Q2
12 quarters
|
|
217
Cummins
CMI
$72.1B
| $174M | 0.09% |
1,548,469
+57,949
| +4% | +$6.56M |
2013 Q2
12 quarters
|
|
218
WEC Energy
WEC
$33.8B
| $173M | 0.09% |
2,655,684
+4,158
| +0.2% | +$250K |
2013 Q2
12 quarters
|
|
219
Illumina
ILMN
$42B
| $173M | 0.09% |
1,269,402
+51,941
| +4% | +$7.38M |
2013 Q2
12 quarters
|
|
220
Corning
GLW
$135B
| $173M | 0.09% |
8,448,860
-384,934
| -4% | -$7.72M |
2013 Q2
12 quarters
|
|
221
Marathon Petroleum
MPC
$128B
| $171M | 0.09% |
4,514,588
-107,296
| -2% | -$3.94M |
2013 Q2
12 quarters
|
|
222
J.M. Smucker
SJM
$12.8B
| $171M | 0.09% |
1,124,106
+141,877
| +14% | +$18.9M |
2013 Q2
12 quarters
|
|
223
VF Corp
VFC
$5.9B
| $171M | 0.09% |
2,953,849
-56,195
| -2% | -$3.32M |
2013 Q2
12 quarters
|
|
224
Vertex Pharmaceuticals
VRTX
$129B
| $171M | 0.09% |
1,987,549
+1,362
| +0.1% | +$118K |
2013 Q2
12 quarters
|
|
225
Zoetis
ZTS
$30.9B
| $171M | 0.09% |
3,599,824
-90,037
| -2% | -$4.25M |
2013 Q2
12 quarters
|
|
Similar funds
Geode Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, down 2.4% from $188B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management withdrew a net $8.49B in Q2 2016, closing 127 positions and reducing 984 holdings. Its most notable exit was Affymetrix Inc, an estimated $7.53B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Geode Capital Management opened a new position in S&P Global worth $215M.
- Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
- Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
- Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
- Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53B.
- Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
- Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
- Geode Capital Management's portfolio value fell 2.4% quarter-over-quarter to $184B.
Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.